![Caxton Associates](images/entities/50/resize_caxton.jpg)
Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
-
Form 4 Strongbridge Biopharma For: Oct 05 Filed by: CAXTON CORP
-
Form SC 13G Xeris Biopharma Holdings Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
WM Technology, Inc (MAPS) Announces it Board of Directors
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Form D/A HedgeForum Caxton, Ltd.
-
Form D/A Caxton Macro (USA) LLC
-
Form D/A Caxton Global Investment
-
Form D/A Caxton Dynamis (USA)
-
Form D/A Caxton Advantage (USA)
-
Form SC 13G Savara Inc Filed by: CAXTON CORP
-
Form SC 13G/A Sierra Oncology, Inc. Filed by: CAXTON CORP
-
Form SC 13G/A CTI BIOPHARMA CORP Filed by: CAXTON CORP
-
Form SC 13G Addex Therapeutics Ltd. Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13G/A Cardiff Oncology, Inc. Filed by: CAXTON CORP
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form 13F-HR CAXTON ASSOCIATES LP For: Sep 30
-
Form 13F-HR CAXTON CORP For: Sep 30
-
Form SC 13G Rezolute, Inc. Filed by: CAXTON CORP
-
Form SC 13G CTI BIOPHARMA CORP Filed by: CAXTON CORP
-
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
-
Form 13F-HR CAXTON ASSOCIATES LP For: Jun 30
-
Form 13F-HR/A CAXTON CORP For: Jun 30
-
Form 13F-HR CAXTON CORP For: Jun 30
-
Form D/A Caxton Macro (USA) LLC
-
Form D/A Caxton Global Investment
-
Form D/A Caxton Advantage (USA)
-
Form SC 13G Cardiff Oncology, Inc. Filed by: CAXTON CORP
-
Cardiff Oncology (CRDF) Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
-
Form 13F-HR CAXTON ASSOCIATES LP For: Mar 31
-
Form 13F-HR CAXTON CORP For: Mar 31
-
Form D/A Caxton Dynamis (USA)
-
Form 13F-HR CAXTON ASSOCIATES LP For: Dec 31
-
Form SC 13G/A SUNESIS PHARMACEUTICALS Filed by: CAXTON CORP
-
Form SC 13G/A Alcentra Capital Corp Filed by: CAXTON CORP
-
Form SC 13G/A Garrison Capital Inc. Filed by: CAXTON CORP
-
Form SC 13G/A SCYNEXIS INC Filed by: CAXTON CORP
-
Form SC 13G/A Satsuma Pharmaceuticals, Filed by: CAXTON CORP
-
Form SC 13G/A Investcorp Credit Manage Filed by: CAXTON CORP
-
Form 13F-HR CAXTON CORP For: Dec 31
-
Form SC 13G Sierra Oncology, Inc. Filed by: CAXTON CORP